Search

everythinglearnresearchcommunity

for

Search:↓

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Testosterone's muscle-building effects do not require its conversion to DHT.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Layer-by-Layer self-assembly is promising for biomedical uses like tissue engineering and cell therapy, but challenges remain in material safety and process optimization.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Polyamines help fix DNA damage accurately in cells.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

Iontophoresis improves minoxidil delivery for alopecia treatment.

Children with marasmus have more resting hair follicles and thinner, less pigmented hair, showing long-term malnutrition.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.